Demonstration of innate immune responses in the thyroid gland: Potential to sense danger and a possible trigger for autoimmune reactions

Thyroid

Volumn 23, Issue 4, 2013, Pages 477-487

  Kawashima, Akira ^a   Yamazaki, Kazuko ^b   Hara, Takeshi ^a   Akama, Takeshi ^a   Yoshihara, Aya ^a   Sue, Mariko ^a   Tanigawa, Kazunari ^a   Wu, Huhehasi ^a   Ishido, Yuko ^a   Takeshita, Fumihiko ^c   Ishii, Norihisa ^a   Sato, Kanji ^d   Suzuki, Koichi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Kanaji Hospital   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHEMOKINE; DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; IODIDE; MESSENGER RNA; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CELL; THYROID GLAND; TREATMENT RESPONSE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL LINE; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; MICE; RATS; RNA, MESSENGER; THYROID DISEASES; THYROID GLAND; TOLL-LIKE RECEPTORS;

EID: 84875720623     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0480     Document Type: Article

References (53)

1. Weetman AP 2004 Autoimmune thyroid disease. Autoimmunity 37:337-340.
2. Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, Kumahara Y 1978 Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab 46:859-862.
3. Raspe E, Costagliola S, Ruf J, Mariotti S, Dumont JE, Ludgate M 1995 Identification of the thyroid Na + /I - cotransporter as a potential autoantigen in thyroid autoimmune disease. Eur J Endocrinol 132:399-405.
4. Yoshida A, Hisatome I, Taniguchi S, Shirayoshi Y, Yamamoto Y, Miake J, Ohkura T, Akama T, Igawa O, Shigemasa C, Kamijo K, Ikuyama S, Caturegli P, Suzuki K 2009 Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab 94:442-448.
5. Ealey PA, Kohn LD, Ekins RP, Marshall NJ 1984 Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators. J Clin Endocrinol Metab 58:909-914.
6. Aderem A, Ulevitch RJ 2000 Toll-like receptors in the induction of the innate immune response. Nature 406:782-787.
7. Kawai T, Akira S 2010 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373-384.
8. Kawashima A, Tanigawa K, Akama T, Yoshihara A, Ishii N, Suzuki K 2011 Innate immune activation and thyroid autoimmunity. J Clin Endocrinol Metab 96:3661-3671.
9. Takeda K, Akira S 2005 Toll-like receptors in innate immunity. Int Immunol 17:1-14.
10. Bekeredjian-Ding I, Jego G 2009 Toll-like receptors-sentries in the B-cell response. Immunology 128:311-323.
11. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM 1996 CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93:2879-2883.
12. Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, Goldsmith PK, Wang Y, Venzon D, Epstein SL, Segal DM 2011 TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-resentation, CTL responses, and antiviral protection. J Immunol 186:2422-2429.
13. Bartholomeu DC, Ropert C, Melo MB, Parroche P, Junqueira CF, Teixeira SM, Sirois C, Kasperkovitz P, Knetter CF, Lien E, Latz E, Golenbock DT, Gazzinelli RT 2008 Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. J Immunol 181:1333-1344.
14. Prantner D, Darville T, Nagarajan UM 2010 Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection. J Immunol 184:2551-2560.
15. Takeuchi O, Akira S 2010 Pattern recognition receptors and inflammation. Cell 140:805-820.
16. Kufer TA, Sansonetti PJ 2011 NLR functions beyond pathogen recognition. Nat Immunol 12:121-128.
17. Munz C, Lunemann JD, Getts MT, Miller SD 2009 Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246-258.
18. Chervonsky AV 2010 Influence of microbial environment on autoimmunity. Nat Immunol 11:28-35.
19. Harii N, Lewis CJ, Vasko V, McCall K, Benavides-eralta U, Sun X, Ringel MD, Saji M, Giuliani C, Napolitano G, Goetz DJ, Kohn LD 2005 Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Mol Endocrinol 19:1231-1250.
20. Yamazaki K, Suzuki K, Yamada E, Yamada T, Takeshita F, Matsumoto M, Mitsuhashi T, Obara T, Takano K, Sato K 2007 Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles. Endocrinology 148:3226-3235.
21. Nicola JP,Nazar M, Mascanfroni ID, Pellizas CG,Masini-Repiso AM2010 NF-kappaB p65 subunitmediates lipopolysaccharideinduced Na (+) /I (-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8. Mol Endocrinol 24:1846-1862.
22. Nicola JP, Velez ML, Lucero AM, Fozzatti L, Pellizas CG, Masini-Repiso AM 2009 Functional toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells. Endocrinology 150:500-508.
23. Kono H, Rock KL 2008 How dying cells alert the immune system to danger. Nat Rev Immunol 8:279-289.
24. Matzinger P 2002 The danger model: a renewed sense of self. Science 296:301-305.
25. Green DR, Ferguson T, Zitvogel L, Kroemer G 2009 Immunogenic and tolerogenic cell death. Nat Rev Immunol 9:353-363.
26. Kawashima A, Tanigawa K, Akama T, Wu H, Sue M, Yoshihara A, Ishido Y, Kobiyama K, Takeshita F, Ishii KJ, Hirano H, Kimura H, Sakai T, Ishii N, Suzuki K 2011 Fragments of genomic DNA released by injured cells activate innate immunity and suppress endocrine function in the thyroid. Endocrinology 152:1702-1712.
27. Suzuki K, Mori A, Saito J, Moriyama E, Ullianich L, Kohn LD 1999 Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology 140:5422-5430.
28. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM 2001 Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 167:2602-2607.
29. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S 2006A Tolllike receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7:40-48.
30. Jacobson EM, Tomer Y 2007 The genetic basis of thyroid autoimmunity. Thyroid 17:949-961.
31. Yamazaki K, Tanigawa K, Suzuki K, Yamada E, Yamada T, Takano K, Obara T, Sato K 2010 Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin. Thyroid 20:67-76.
32. Suzuki K, Mori A, Ishii KJ, Saito J, Singer DS, Klinman DM, Krause PR, Kohn LD 1999 Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci USA 96:2285-2290.
33. Tanigawa K, Suzuki K, Kimura H, Takeshita F, Wu H, Akama T, Kawashima A, Ishii N 2009 Tryptophan aspartatecontaining coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection. Clin Exp Immunol 156:495-501.
34. Takeshita F, Suzuki K, Sasaki S, Ishii N, Klinman DM, Ishii KJ 2004 Transcriptional regulation of the human TLR9 gene. J Immunol 173:2552-2561.
35. Leoni SG, Kimura ET, Santisteban P, De la Vieja A 2011 Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid responses to iodide excess. Mol Endocrinol 25:1924-1935.
36. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF 1995 Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 147:311-320.
37. Sharma R, Traore K, Trush MA, Rose NR, Burek CL 2008 Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of non-obese diabetic.H2(h4) mice is reactive oxygen species-dependent. Clin Exp Immunol 152: 13-20.
38. Golstein J, Dumont JE 1996 Cytotoxic effects of iodide on thyroid cells: difference between rat thyroid FRTL-5 cell and primary dog thyrocyte responsiveness. J Endocrinol Invest 19:119-126.
39. Suzuki K, Kimura H, Wu H, Kudo N, Kim WB, Suzuki S, Yoshida A, Caturegli P, Kohn LD 2010 Excess iodide decreases transcription of NIS and VEGF genes in rat FRTL-5 thyroid cells. Biochem Biophys Res Commun 393:286-290.
40. Yoshimura A, Wakabayashi Y, Mori T 2010 Cellular and molecular basis for the regulation of inflammation by TGFbeta. J Biochem 147:781-792.
41. Pisarev MA, Thomasz L, Juvenal GJ 2009 Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid 19:881-892.
42. Costamagna E, Garcia B, Santisteban P 2004 The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factorbeta repression of the sodium/iodide symporter gene. J Biol Chem 279:3439-3446.
43. Nicolussi A, D'Inzeo S, Santulli M, Colletta G, Coppa A 2003 TGF-beta control of rat thyroid follicular cells differentiation. Mol Cell Endocrinol 207:1-11.
44. Pupjalis D, Goetsch J, Kottas DJ, Gerke V, Rescher U 2011 Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol Med 3:102-114.
45. Takeshita F, Tanaka T, Matsuda T, Tozuka M, Kobiyama K, Saha S, Matsui K, Ishii KJ, Coban C, Akira S, Ishii N, Suzuki K, Klinman DM, Okuda K, Sasaki S 2006 Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol 80:6218-6224.
46. Kobiyama K, Takeshita F, Jounai N, Sakaue-Sawano A, Miyawaki A, Ishii KJ, Kawai T, Sasaki S, Hirano H, Ishii N, Okuda K, Suzuki K 2010 Extrachromosomal histone H2B mediates innate antiviral immune responses induced by intracellular double-stranded DNA. J Virol 84:822-832.
47. Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN 2007 TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13:543-551.
48. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell LE, Al-Shamkhani A, Flavell R, Borrow P, Reis e Sousa C 2003 Viral infection switches non-lasmacytoid dendritic cells into high interferon producers. Nature 424:324-328.
49. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
50. Kong L, Ge BX 2008 MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Res 18:745-755.
51. Suzuki K, Lavaroni S, Mori A, Yamamoto K, Yi X, Miyagi E, Katoh R, Kohn LD, Kawaoi A 1999 Thyroglobulin: a master regulator of follicular function via transcriptional suppression of thyroid specific genes. Acta Histochem Cytochem 32:111-119.
52. Davidson TS, DiPaolo RJ, Andersson J, Shevach EM 2007 Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3 + T regulatory cells. J Immunol 178:4022- 4026.
53. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA 2006 Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99-146.